Bacteria: Gram-negative

Haemophilus ducreyi

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

A Gram-negative coccobacillus that causes chancroid, a sexually transmitted genital ulcer disease now uncommon in the United States.

Infections

Chancroid: painful genital ulcers with tender, sometimes draining, lymph nodes in the groin. Rare in the United States; genital ulcers increase the risk of HIV transmission.

Signs and symptoms

Painful genital ulcer with ragged edges and tender, sometimes suppurative, inguinal lymph nodes.

Antibiotic and antimicrobial resistance

Resistance to some older agents has been reported; the regimens in the CDC STI treatment guidelines remain effective.

Treatment considerations

Azithromycin, ceftriaxone, ciprofloxacin or erythromycin per CDC guidelines; test for HIV and syphilis.

Infection control and public health

Partner evaluation and treatment.

Gram-negative Haemophilus ducreyi in chains, gentian violet stain
Haemophilus ducreyi, gentian violet stain. CDC Public Health Image Library; public domain. Image source
Gram-negative coccobacilli, schematic
Gram-negative coccobacilli. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Chancroid (STI Treatment Guidelines).
  2. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.